@FierceBiotech: J&J's success with Hep C partners might hit a snag. Story | Follow @FierceBiotech
> Impax Pharmaceuticals, division of Impax Laboratories ($IPXL), says that it has received $400,000 from The Michael J. Fox Foundation to continue developing IPX066, an extended release carbidopa-levodopa for patients with Parkinson's disease. Release
> Seeking Alpha has a story about how cancer drug developer Endocyte ($ECYT) has made strides with its stock price since its IPO in February, boosted by the prospects of its experimental treatment for advanced ovarian cancer. Report
> Inovio Pharmaceuticals ($INO) said today that it has seen "significant" immune responses in an initial clinical trial of its DNA vaccine called VGX-3400X for avian H5N1 influenza. Item
> James Hoyes has been named president of EMD Serono, the U.S. affiliate of German pharmaceutical maker Merck KGaA. He will also be a member of the executive management board of Merck Serono. Announcement
> Regeneron ($REGN) financial chief Murray Goldberg told Xconomy's Arlene Weintraub that collaborations with companies like French drug giant Sanofi ($SNY) have put the company in the "top tier" in drug R&D. Article
@FiercePharma: Note to Pfizer: Bayer shopping for vet buys. Article | Follow @FiercePharma
> Merck job cuts set to accelerate. Item
> Expect more pharma M&A, less pharma hiring. Report
> Yervoy may help BMS survive European squeeze. More
> FDA taps Dartmouth ex-dean for new post. Story
> French minister overhauls pharma regs. Article
Manufacturing News
> Indian pharmas seek to protect their edge Report
> Corpedia, Second City bring comedy to compliance training. Item
> Hamburg appoints FDA deputies; Spielberg oversees drugs. Report
> GSK's Witty: West can compete in manufacturing. Story
> Pew track/trace call highlights congressional dallying. News
> Expert: Boost audit programs to keep up with outsourcing More
Vaccines News
> With Gates Foundation backing, Liquidia advances novel flu vaccine. Item
> Shingles vaccination levels fall short of expectations. Report
> Crucell and Scripps find antibody for universal flu vax. News
> The CIA, bin Laden and the future of vaccine programs. Story
> GSK gets Boostrix approval for adults over 65. Article
> Microneedles may be better for H1N1 delivery. More